Artiva Biotherapeutics, Inc. 10-Q filing
Filed 2026-05-08 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-213242
- Form type
- 10-Q
- CIK
- 0001817241
- Primary document
- https://www.sec.gov/Archives/edgar/data/1817241/000119312526213242/artv-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Artiva Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-24.4M | - | - |
| Net Income | $-23.5M | - | - |
| Eps Basic | -0.95 | - | - |
| Eps Diluted | -0.95 | - | - |
| Cash And Equivalents | $21.0M | - | - |
| Total Assets | $106.0M | - | - |
| Total Liabilities | $18.1M | - | - |
| Shareholders Equity | $87.8M | - | - |
| Operating Cash Flow | $-20.9M | - | - |
| Capital Expenditures | $242,000 | - | - |